English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

Hartinger, C. G., Zorbas-Seifried, S., Jakupec, M. A., Kynast, B., Zorbas, H., & Keppler, B. K. (2006). From bench to bedside - preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). Journal of Inorganic Biochemistry, 100(5-6), 891-904.

Item is

Basic

show hide
Genre: Journal Article
Alternative Title : J. Inorg. Biochem.

Files

show Files

Locators

show

Creators

show
hide
 Creators:
Hartinger, C. G., Author
Zorbas-Seifried, S.1, Author           
Jakupec, M. A., Author
Kynast, B., Author
Zorbas, H.1, Author           
Keppler, B. K., Author
Affiliations:
1Oesterhelt, Dieter / Membrane Biochemistry, Max Planck Institute of Biochemistry, Max Planck Society, ou_1565164              

Content

show
hide
Free keywords: ruthenium(III) complexes; KP1019; FFC14A; anticancer drugs; biological activity; mode of action
 Abstract: -

Details

show
hide
Language(s): eng - English
 Dates: 2006-05
 Publication Status: Issued
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Type: Peer
 Identifiers: eDoc: 288487
ISI: 000238004700003
 Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show
hide
Title: Journal of Inorganic Biochemistry
  Alternative Title : J. Inorg. Biochem.
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 100 (5-6) Sequence Number: - Start / End Page: 891 - 904 Identifier: ISSN: 0162-0134